Clinical management of a patient following a granulocyte transfusion from a donor positive for COVID-19.

Autor:	Woo JS; Department of Pathology and City of Hope National Medical Center, Duarte, CA., Zhuang L; Department of Pathology and City of Hope National Medical Center, Duarte, CA., Jackson R; Department of Pathology and City of Hope National Medical Center, Duarte, CA., Wang S; Department of Pathology and City of Hope National Medical Center, Duarte, CA., Agrawal V; Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Blackmon A; Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Pourhassan H; Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Yuan S; Department of Pathology and City of Hope National Medical Center, Duarte, CA.
Jazyk:	angličtina
Zdroj:	Laboratory medicine [Lab Med] 2024 Jul 03; Vol. 55 (4), pp. 524-527.
DOI:	10.1093/labmed/lmad118
Abstrakt:	Granulocyte transfusions are indicated for patients with severe neutropenia and evidence of bacterial or fungal infection who are unresponsive to standard antimicrobial therapy. With a limited expiration time of 24 hours after collection, granulocytes are often transfused before results of infectious-disease screening tests are available, and before a transfusion service can perform a risk assessment if postdonation information is provided after the collection. The case we describe herein demonstrates a clinical scenario meeting indications for granulocyte transfusion, coupled with the clinical management undertaken after the granulocyte donor disclosed a positive result for a COVID-19 self-test taken 1 day after donation. In this case, the patient did not develop new COVID-19 symptoms and tested negative for COVID-19 after transfusion of the implicated unit. These findings add to the body of evidence in the literature that COVID-19 is not transmitted via blood transfusion. (© The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu